1. Home
  2. MNY vs CALC Comparison

MNY vs CALC Comparison

Compare MNY & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNY
  • CALC
  • Stock Information
  • Founded
  • MNY 2014
  • CALC 2011
  • Country
  • MNY Singapore
  • CALC United States
  • Employees
  • MNY N/A
  • CALC N/A
  • Industry
  • MNY
  • CALC Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNY
  • CALC Health Care
  • Exchange
  • MNY Nasdaq
  • CALC Nasdaq
  • Market Cap
  • MNY 43.9M
  • CALC 48.1M
  • IPO Year
  • MNY N/A
  • CALC N/A
  • Fundamental
  • Price
  • MNY $1.82
  • CALC $2.78
  • Analyst Decision
  • MNY Strong Buy
  • CALC Strong Buy
  • Analyst Count
  • MNY 1
  • CALC 2
  • Target Price
  • MNY $4.00
  • CALC $14.50
  • AVG Volume (30 Days)
  • MNY 167.3K
  • CALC 46.3K
  • Earning Date
  • MNY 09-18-2025
  • CALC 08-12-2025
  • Dividend Yield
  • MNY N/A
  • CALC N/A
  • EPS Growth
  • MNY N/A
  • CALC N/A
  • EPS
  • MNY N/A
  • CALC N/A
  • Revenue
  • MNY $71,649,746.00
  • CALC N/A
  • Revenue This Year
  • MNY $16.97
  • CALC N/A
  • Revenue Next Year
  • MNY $19.35
  • CALC N/A
  • P/E Ratio
  • MNY N/A
  • CALC N/A
  • Revenue Growth
  • MNY N/A
  • CALC N/A
  • 52 Week Low
  • MNY $0.55
  • CALC $1.42
  • 52 Week High
  • MNY $2.15
  • CALC $5.97
  • Technical
  • Relative Strength Index (RSI)
  • MNY 54.86
  • CALC 49.88
  • Support Level
  • MNY $1.70
  • CALC $2.70
  • Resistance Level
  • MNY $2.06
  • CALC $3.00
  • Average True Range (ATR)
  • MNY 0.19
  • CALC 0.25
  • MACD
  • MNY -0.04
  • CALC -0.05
  • Stochastic Oscillator
  • MNY 45.45
  • CALC 57.32

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: